TransCode Therapeutics, Inc.

RNAZ·NasdaqCM
Compare
1.6300−0.2300 (−12.37%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.8600
Open1.9100
Day range1.63001.9100
52-week range1.520015.8970
Off day high−14.66%
Off 52-week high−89.75%
Volume31.64K
Avg. volume (3M)50.57K
Market cap27.60M
EPS (TTM)-52.06
Forward P/E-2.72
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding16.93M
Short interest—
Earnings date—
Analyst target—
Profit margin—

Against its peers

Compare in full ›
RNAZ TVGN HURA AKTX IMMP SLXN
Market cap 27.60M 43.49M 121.08M 19.52M 27.04M 2.58M
P/E (TTM) — — — — — —
Forward P/E -2.7 — -3.1 -1.0 -0.7 -0.3
Price/book -0.1 -1.5 6.6 0.8 0.6 22.3
Dividend yield — — — — — —
1-year change −86.24% −81.03% −19.34% −78.21% −90.88% −99.42%
Today −12.37% −1.50% −3.06% −2.62% +0.27% −16.96%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All RNAZ news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.